These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28189292)

  • 1. Men's sexual response to female partner's intranasal oxytocin administration for hypoactive sexual desire disorder: an open prospective cohort study.
    Muin DA; Sheikh Rezaei S; Tremmel-Scheinost M; Salama M; Luger A; Wolzt M; Husslein PW; Bayerle-Eder M
    Fertil Steril; 2017 Mar; 107(3):781-787.e3. PubMed ID: 28189292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial.
    Muin DA; Wolzt M; Marculescu R; Sheikh Rezaei S; Salama M; Fuchs C; Luger A; Bragagna E; Litschauer B; Bayerle-Eder M
    Fertil Steril; 2015 Sep; 104(3):715-23.e4. PubMed ID: 26151620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Men's Sexual Response to Female Partner's Intranasal Oxytocin Administration for Hypoactive Sexual Desire Disorder: An Open Prospective Cohort Study.
    Seftel AD
    J Urol; 2017 Aug; 198(2):237. PubMed ID: 29370616
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Men's Sexual Response to Female Partner's Intranasal Oxytocin Administration for Hypoactive Sexual Desire Disorder: An Open Prospective Cohort Study.
    Niederberger C
    J Urol; 2018 Jan; 199(1):17. PubMed ID: 29310164
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
    Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
    J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women.
    Pyke RE; Clayton AH
    J Sex Med; 2019 Dec; 16(12):1885-1894. PubMed ID: 31678098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled trial.
    Goldstein I; Fisher WA; Sand M; Rosen RC; Mollen M; Brock G; Karlin G; Pommerville P; Bangerter K; Bandel TJ; Derogatis LR;
    J Sex Med; 2005 Nov; 2(6):819-32. PubMed ID: 16422806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
    Simon JA; Derogatis L; Portman D; Brown L; Yuan J; Kissling R
    J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.
    Katz M; DeRogatis LR; Ackerman R; Hedges P; Lesko L; Garcia M; Sand M;
    J Sex Med; 2013 Jul; 10(7):1807-15. PubMed ID: 23672269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis.
    Achilli C; Pundir J; Ramanathan P; Sabatini L; Hamoda H; Panay N
    Fertil Steril; 2017 Feb; 107(2):475-482.e15. PubMed ID: 27916205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal testosterone gel prn application for hypoactive sexual desire disorder in premenopausal women: a controlled pilot study of the effects on the arizona sexual experiences scale for females and sexual function questionnaire.
    Chudakov B; Ben Zion IZ; Belmaker RH
    J Sex Med; 2007 Jan; 4(1):204-208. PubMed ID: 17233786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
    Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
    J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Tribulus Terrestris for the treatment of premenopausal women with hypoactive sexual desire disorder: a randomized double-blinded, placebo-controlled trial.
    Vale FBC; Zanolla Dias de Souza K; Rezende CR; Geber S
    Gynecol Endocrinol; 2018 May; 34(5):442-445. PubMed ID: 29172782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
    J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women.
    Fabre LF; Brown CS; Smith LC; Derogatis LR
    J Sex Med; 2011 May; 8(5):1411-9. PubMed ID: 21324094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
    Simon J; Braunstein G; Nachtigall L; Utian W; Katz M; Miller S; Waldbaum A; Bouchard C; Derzko C; Buch A; Rodenberg C; Lucas J; Davis S
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5226-33. PubMed ID: 16014407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically relevant changes in sexual desire, satisfying sexual activity and personal distress as measured by the profile of female sexual function, sexual activity log, and personal distress scale in postmenopausal women with hypoactive sexual desire disorder.
    DeRogatis LR; Graziottin A; Bitzer J; Schmitt S; Koochaki PE; Rodenberg C
    J Sex Med; 2009 Jan; 6(1):175-83. PubMed ID: 19170847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partner responses to low desire among couples coping with male hypoactive sexual desire disorder and associations with sexual well-being.
    Belu CF; Corsini-Munt S; Dubé JP; Wang GA; Rosen NO
    J Sex Med; 2023 Jun; 20(7):955-964. PubMed ID: 37280187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
    Goldfischer ER; Breaux J; Katz M; Kaufman J; Smith WB; Kimura T; Sand M; Pyke R
    J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which are the male factors associated with female sexual dysfunction (FSD)?
    Maseroli E; Fanni E; Mannucci E; Fambrini M; Jannini EA; Maggi M; Vignozzi L
    Andrology; 2016 Sep; 4(5):911-20. PubMed ID: 27409983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.